Releasing the brake: Targeting Cbl-b to enhance lymphocyte effector functions

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Wallner, Stephanie ^a   Gruber, Thomas ^a   Baier, Gottfried ^a   Wolf, Dominik ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; GAMMA INTERFERON; PHOSPHATIDYLINOSITOL 3 KINASE; RING FINGER PROTEIN; TRANSCRIPTION FACTOR NFAT; UBIQUITIN PROTEIN LIGASE E3; CANCER VACCINE; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL EFFECTIVENESS; ENZYME ACTIVITY; GENE DELETION; GENE MUTATION; LYMPHOCYTE FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ADOPTIVE TRANSFER; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; NEOPLASM;

ADOPTIVE TRANSFER; ANIMALS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-CBL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84861040048     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/692639     Document Type: Review

References (31)

1. Bachmaier K., Krawczyk C., Kozieradzki I., Kong Y. Y., Sasaki T., Oliveira-Dos-Santos A., Mariathasan S., Bouchard D., Wakeham A., Itie A., Le J., Ohashi P. S., Sarosi I., Nishina H., Lipkowitz S., Penninger J. M., Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b Nature 2000 403 6766 211 216 (Pubitemid 30050966)
2. Chiang Y. J., Kole H. K., Brown K., Naramura M., Fukuhara S., Hu R. J., Jang I. K., Gutkind J. S., Shevach E., Gu H., Cbl-b regulates the CD28 dependence of T-cell activation Nature 2000 403 6766 216 220 (Pubitemid 30050967)
3. Langdon W. Y., Hartley J. W., Klinken S. P., Ruscetti S. K., Morse H. C., v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas Proceedings of the National Academy of Sciences of the United States of America 1989 86 4 1168 1172 (Pubitemid 19061515)
4. Heissmeyer V., Macin F., Im S. H., Varma R., Feske S., Venuprasad K., Gu H., Liu Y. C., Dustin M. L., Rao A., Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins Nature Immunology 2004 5 3 255 265 (Pubitemid 38332122)
5. Hershko A., Ciechanover A., The ubiquitin system Annual Review of Biochemistry 1998 67 425 479 (Pubitemid 28411135)
6. Sorkin A., Von Zastrow M., Signal transduction and endocytosis: close encounters of many kinds Nature Reviews Molecular Cell Biology 2002 3 8 600 614
7. O'Neill L. A. J., Regulation of signaling by non-degradative ubiquitination Journal of Biological Chemistry 2009 284 13 8209
8. Nau M. M., Lipkowitz S., Comparative genomic organization of the cbl genes Gene 2003 308 1-2 103 113 (Pubitemid 36597828)
9. Schmidt M. H. H., Dikic I., The Cbl interactome and its functions Nature Reviews Molecular Cell Biology 2005 6 12 907 918 (Pubitemid 41778710)
10. Staub O., Rotin D., Role of ubiquitylation in cellular membrane transport Physiological Reviews 2006 86 2 669 707
11. Joazeiro C. A. P., Wing S. S., Huang H. K., Leverson J. D., Hunter T., Liu Y. C., The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase Science 1999 286 5438 309 312 (Pubitemid 29484697)
12. Zheng N., Wang P., Jeffrey P. D., Pavletich N. P., Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases Cell 2000 102 4 533 539
13. Waterman H., Levkowitz G., Alroy I., Yarden Y., The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor Journal of Biological Chemistry 1999 274 32 22151 22154
14. Ettenberg S. A., Magnifico A., Cuello M., Nau M. M., Rubinstein Y. R., Yarden Y., Weissman A. M., Lipkowitz S., Cbl-b -dependent coordinated degradation of the epidermal growth factor receptor signaling complex Journal of Biological Chemistry 2001 276 29 27677 27684
15. Paolino M., Thien C. B.F., Gruber T., Hinterleitner R., Baier G., Langdon W. Y., Penninger J. M., Essential role of E3 ubiquitin ligase activity in Cbl-b -regulated T cell functions Journal of Immunology 2011 186 4 2138 2147
16. Chan A. C., Dalton M., Johnson R., Kong G., Wang T., Thoma R., Kurosaki T., Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function The EMBO Journal 1995 14 11 2499 2508
17. Wardenburg J. B., Fu C., Jackman J. K., Flotow H., Wilkinson S. E., Williams D. H., Johnson R., Kong G., Chan A. C., Findel P. R., Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function Journal of Biological Chemistry 1996 271 33 19641 19644 (Pubitemid 26281693)
18. Samelson L. E., Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins Annual Review of Immunology 2002 20 371 394 (Pubitemid 34293429)
19. Fischer K. D., Kong Y. Y., Nishina H., Tedford K., Marengre L. E. M., Kozieradzki I., Sasaki T., Starr M., Chan G., Gardener S., Nghiem M. P., Bouchard D., Barbacid M., Bernstein A., Penninger J. M., Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor Current Biology 1998 8 10 554 562 (Pubitemid 28222889)
20. Gruber T., Hermann-Kleiter N., Hinterleitner R., Fresser F., Schneider R., Gastl G., Penninger J. M., Baier G., PKC- modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation Science Signaling 2009 2 76, article ra30
21. Lutz-Nicoladoni C., Wallner S., Stoitzner P., Pircher M., Gruber T., Wolf A. M., Gastl G., Penninger J. M., Baier G., Wolf D., Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8 + T cells combined with a DC vaccine Immunology and Cell Biology 2012 90 1 130 134
22. Jeon M. S., Atfield A., Venuprasad K., Krawczyk C., Sarao R., Elly C., Yang C., Arya S., Bachmaier K., Su L., Bouchard D., Jones R., Gronski M., Ohashi P., Wada T., Bloom D., Fathman C. G., Liu Y. C., Penninger J. M., Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction Immunity 2004 21 2 167 177 (Pubitemid 39094047)
23. Safford M., Collins S., Lutz M. A., Allen A., Huang C. T., Kowalski J., Blackford A., Horton M. R., Drake C., Schwartz R. H., Powell J. D., Egr-2 and Egr-3 are negative regulators of T cell activation Nature Immunology 2005 6 5 472 480 (Pubitemid 41716760)
24. Fang D., Liu Y. C., Proteolysis-independent regulation of P13K by Cbl-b -mediated ubiquitination in T cells Nature Immunology 2001 2 9 870 875
25. Gronski M. A., Boulter J. M., Moskophidis D., Nguyen L. T., Holmberg K., Elford A. R., Deenick E. K., Kim H. O., Penninger J. M., Odermatt B., Gallimore A., Gascoigne N. R. J., Ohashi P. S., TCR affinity and negative regulation limit autoimmunity Nature Medicine 2004 10 11 1234 1239 (Pubitemid 39540441)
26. Wohlfert E. A., Gorelik L., Mittler R., Flavell R. A., Clark R. B., Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF- sensitivity in vitro and in vivo Journal of Immunology 2006 176 3 1316 1320 (Pubitemid 43134271)
27. Wohlfert E. A., Callahan M. K., Clark R. B., Resistance to CD4 + CD25 + regulatory T cells and TGF- in Cbl-b -/- mice Journal of Immunology 2004 173 2 1059 1065
28. Harada Y., Harada Y., Elly C., Ying G., Paik J. H., DePinho R. A., Liu Y. C., Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells Journal of Experimental Medicine 2010 207 7 1381 1391
29. Loeser S., Loser K., Bijker M. S., Rangachari M., van der Burg S. H., Wada T., Beissert S., Melief C. J. M., Penninger J. M., Spontaneous tumor rejection by Cbl-b -deficient CD8 + T cells Journal of Experimental Medicine 2007 204 4 879 891 (Pubitemid 46631616)
30. Chiang J. Y., Jang I. K., Hodes R., Gu H., Ablation of Cbl-b provides protection against transplanted and spontaneous tumors Journal of Clinical Investigation 2007 117 4 1029 1036 (Pubitemid 46556759)
31. Yang T., Martin M. L., Nielsen J. S., Milne K., Wall E. M., Lin W., Watson P. H., Nelson B. H., Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8 + T cells lacking the Cbl-b gene Cancer Immunology, Immunotherapy 2009 58 11 1865 1875